MedPath

Effectiveness of MST Versus ECT for Major Depressive Episode

Not Applicable
Recruiting
Conditions
Major Depressive Disorder (MDD)
Registration Number
NCT06409325
Lead Sponsor
Shanghai Mental Health Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
210
Inclusion Criteria

Inclusion Criteria:<br><br> - Participants must meet the diagnostic criteria for MDD as outlined in the Diagnostic<br> and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).<br><br> - Participants must have a baseline score of 18 or higher on the 24-item Hamilton<br> Depression Rating Scale (HDRS-24).<br><br> - During the trial's treatment period, participants must be using a single<br> antidepressant medication at a stable dose.<br><br> - Participants must be between the ages of 18 and 65 years.<br><br> - Informed consent from both parents and legal guardians is required.<br><br>Exclusion Criteria:<br><br> - Individuals with current or history of organic brain disorders or neurological<br> disorders will be excluded from the study.<br><br> - Participants with a Wechsler Abbreviated Scale of Intelligence (WASI) score of less<br> than 70 will be excluded.<br><br> - Individuals currently taking antiepileptic drugs, benzodiazepines, or other<br> medications that may affect seizure activity will be excluded from the study.<br><br> - Those with exposure to ECT, modified ECT, MST, transcranial magnetic stimulation<br> (TMS), transcranial direct current stimulation (tDCS), transcranial alternating<br> current stimulation (tACS), or other neurostimulation treatments in last 6 months<br> will be excluded.<br><br> - Individuals with cochlear implants, cardiac pacemakers, implanted devices, or metal<br> in the brain will be excluded from participation.<br><br> - Pregnant or lactating individuals will be excluded from the study.<br><br> - Individuals currently participating in another concurrent clinical trial will not be<br> eligible for inclusion.<br><br> - Participants who refuse to provide informed consent to participate in the trial will<br> be excluded.<br><br> - Other circumstances deemed unsuitable for participation by researchers will result<br> in exclusion.

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the response rate;the remission rate
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath